These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 834188)
21. Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux. Bormio Nunes JH; Hager S; Mathuber M; Pósa V; Roller A; Enyedy ÉA; Stefanelli A; Berger W; Keppler BK; Heffeter P; Kowol CR J Med Chem; 2020 Nov; 63(22):13719-13732. PubMed ID: 33190481 [TBL] [Abstract][Full Text] [Related]
22. Concerning the role of zinc in the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazonato) zinc(II) and related chelates. Petering DH Biochem Pharmacol; 1974 Feb; 23(3):567-76. PubMed ID: 4207164 [No Abstract] [Full Text] [Related]
23. [Siderophores--the carriers of the iron ion]. Chimiak A Postepy Biochem; 1984; 30(3-4):435-60. PubMed ID: 6242126 [No Abstract] [Full Text] [Related]
24. Interaction of neocuproine, 1,10-phenanthroline and 2,2'-dipyridyl with human ceruloplasmin. Løvstad RA Int J Biochem; 1988; 20(1):117-9. PubMed ID: 3342923 [TBL] [Abstract][Full Text] [Related]
25. The physiological disposition of 14C-labeled 5-hydroxy-pyridine-2-carboxaldehyde thiosemicarbazone (NSC-107,392) in mice. Tomchick R; Weinstein EP; Mead JA Biochem Med; 1972 Jun; 6(3):282-93. PubMed ID: 5041896 [No Abstract] [Full Text] [Related]
26. Alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone inhibitors of ribonucleoside diphosphate reductase. Booth BA; Agrawal KC; Moore EC; Sartorelli AC Cancer Res; 1974 Jun; 34(6):1308-14. PubMed ID: 4363653 [No Abstract] [Full Text] [Related]
27. [Iron absorption]. Ganzoni AM Schweiz Med Wochenschr; 1971 Nov; 101(44):1569-75. PubMed ID: 4946687 [No Abstract] [Full Text] [Related]
28. Redox-dependent structural changes in an engineered heme-copper center in myoglobin: insights into chloride binding to CuB in heme copper oxidases. Zhao X; Nilges MJ; Lu Y Biochemistry; 2005 May; 44(17):6559-64. PubMed ID: 15850389 [TBL] [Abstract][Full Text] [Related]
30. Equilibrium and kinetic studies of iron(II) and iron(III) complexes of some alpha (N)-heterocyclic thiosemicarbazones. Reduction of the iron(III) complexes of 2-formylpyridine thiosemicarbazone and 2-acetylpyridine thiosemicarbazone by cellular thiol-like reducing agents. Borges RH; Paniago E; Beraldo H J Inorg Biochem; 1997 Mar; 65(4):267-75. PubMed ID: 9046107 [TBL] [Abstract][Full Text] [Related]
31. Copper complexes of thiosemicarbazone-pyridylhydrazine (THYNIC) hybrid ligands: a new versatile potential bifunctional chelator for copper radiopharmaceuticals. Cowley AR; Dilworth JR; Donnelly PS; White JM Inorg Chem; 2006 Jan; 45(2):496-8. PubMed ID: 16411680 [TBL] [Abstract][Full Text] [Related]
32. Copper and the autoxidation of hemoglobin. Rifkind JM Biochemistry; 1974 Jun; 13(12):2475-81. PubMed ID: 4831899 [No Abstract] [Full Text] [Related]
33. X-ray crystallographic analyses of complexes between bovine beta-trypsin and Schiff base copper(II) or iron(III) chelates. Toyota E; Ng KK; Sekizaki H; Itoh K; Tanizawa K; James MN J Mol Biol; 2001 Jan; 305(3):471-9. PubMed ID: 11152605 [TBL] [Abstract][Full Text] [Related]
35. Copper(I)-dioxygen reactivity of [(L)Cu(I)](+) (L = tris(2-pyridylmethyl)amine): kinetic/thermodynamic and spectroscopic studies concerning the formation of Cu-O2 and Cu2-O2 adducts as a function of solvent medium and 4-pyridyl ligand substituent variations. Zhang CX; Kaderli S; Costas M; Kim EI; Neuhold YM; Karlin KD; Zuberbühler AD Inorg Chem; 2003 Mar; 42(6):1807-24. PubMed ID: 12639113 [TBL] [Abstract][Full Text] [Related]
37. Understanding the metabolism of the anticancer drug Triapine: electrochemical oxidation, microsomal incubation and in vivo analysis using LC-HRMS. Pelivan K; Frensemeier L; Karst U; Koellensperger G; Bielec B; Hager S; Heffeter P; Keppler BK; Kowol CR Analyst; 2017 Aug; 142(17):3165-3176. PubMed ID: 28745337 [TBL] [Abstract][Full Text] [Related]
38. Iron chelators of the dipyridylketone thiosemicarbazone class: precomplexation and transmetalation effects on anticancer activity. Bernhardt PV; Sharpe PC; Islam M; Lovejoy DB; Kalinowski DS; Richardson DR J Med Chem; 2009 Jan; 52(2):407-15. PubMed ID: 19090766 [TBL] [Abstract][Full Text] [Related]
39. The chemistry and biological activity of alpha -(N)-heterocyclic carboxaldehyde thiosemicarbazones. Agrawal KC; Sartorelli AC Prog Med Chem; 1978; 15():321-56. PubMed ID: 400614 [No Abstract] [Full Text] [Related]
40. Role of chelatable iron versus myoglobin in oxidative stress after crush trauma. Rehberg S; Thiemermann C; Maybauer MO Shock; 2010 May; 33(5):552-3. PubMed ID: 19789458 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]